CANNAPHARMARX, INC. Convertible Notes Payable, Current
CANNAPHARMARX, INC. (CPMD) had Convertible Notes Payable, Current of $1.02 million as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-05-20
- 2026-03-31: Convertible Notes Payable, Current $1.02M.
- 2025-12-31: Convertible Notes Payable, Current $1.02M.
- 2025-09-30: Convertible Notes Payable, Current $318.64K.
- 2025-06-30: Convertible Notes Payable, Current $487.72K.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2026-03-31 | $1.02M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $1.02M 10-Q · filed 2026-05-20 | |
| 2025-09-30 | $318.64K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $487.72K 10-Q · filed 2025-08-14 | |
| 2024-12-31 | $1.30M 10-K · filed 2026-03-31 | $408.04K 10-Q · filed 2025-08-14 |
| 2022-09-30 | $1.06M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $1.06M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $949.76K 10-Q · filed 2022-05-23 | |
| 2021-12-31 | $775.45K 10-Q · filed 2022-11-21 | |
| 2021-09-30 | $845.08K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $812.79K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.05M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $997.56K 10-K · filed 2022-04-15 | |
| 2020-09-30 | $1.75M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.59M 10-Q · filed 2020-08-19 | |
| 2020-03-31 | $1.00M 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $552.60K 10-K · filed 2021-04-14 | |
| 2019-09-30 | $200.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $2.07M 10-K · filed 2020-05-27 | |
| 2018-09-30 | $905.00K 10-Q · filed 2018-11-13 | |
| 2017-12-31 | $0.00 10-K · filed 2019-04-03 |